Annual Total Liabilities
$64.29 M
-$8.85 M-12.10%
31 December 2023
Summary:
Harvard Bioscience annual total liabilities is currently $64.29 million, with the most recent change of -$8.85 million (-12.10%) on 31 December 2023. During the last 3 years, it has fallen by -$14.65 million (-18.56%). HBIO annual total liabilities is now -25.15% below its all-time high of $85.89 million, reached on 31 December 2018.HBIO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$65.92 M
+$4.25 M+6.90%
30 September 2024
Summary:
Harvard Bioscience quarterly total liabilities is currently $65.92 million, with the most recent change of +$4.25 million (+6.90%) on 30 September 2024. Over the past year, it has increased by +$1.63 million (+2.53%). HBIO quarterly total liabilities is now -28.08% below its all-time high of $91.65 million, reached on 31 March 2018.HBIO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HBIO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +2.5% |
| 3 y3 years | -18.6% | -16.5% |
| 5 y5 years | -22.7% | -20.8% |
HBIO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.6% | at low | -19.3% | +6.9% |
| 5 y | 5 years | -22.7% | at low | -20.8% | +6.9% |
| alltime | all time | -25.1% | +893.1% | -28.1% | +1301.6% |
Harvard Bioscience Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $65.92 M(+6.9%) |
| June 2024 | - | $61.66 M(-4.2%) |
| Mar 2024 | - | $64.35 M(+0.1%) |
| Dec 2023 | $64.29 M(-12.1%) | $64.29 M(-1.8%) |
| Sept 2023 | - | $65.45 M(-3.1%) |
| June 2023 | - | $67.51 M(-5.2%) |
| Mar 2023 | - | $71.24 M(-2.6%) |
| Dec 2022 | $73.14 M(-7.4%) | $73.14 M(-2.5%) |
| Sept 2022 | - | $75.03 M(-3.5%) |
| June 2022 | - | $77.77 M(-4.8%) |
| Mar 2022 | - | $81.67 M(+3.5%) |
| Dec 2021 | $78.94 M(-0.8%) | $78.94 M(+2.5%) |
| Sept 2021 | - | $76.98 M(+2.3%) |
| June 2021 | - | $75.27 M(+1.5%) |
| Mar 2021 | - | $74.13 M(-6.8%) |
| Dec 2020 | $79.57 M(-4.3%) | $79.57 M(+9.8%) |
| Sept 2020 | - | $72.45 M(-2.9%) |
| June 2020 | - | $74.62 M(-7.0%) |
| Mar 2020 | - | $80.25 M(-3.5%) |
| Dec 2019 | $83.18 M(-3.2%) | $83.18 M(-2.9%) |
| Sept 2019 | - | $85.67 M(-0.3%) |
| June 2019 | - | $85.91 M(-5.6%) |
| Mar 2019 | - | $90.99 M(+5.9%) |
| Dec 2018 | $85.89 M(+201.9%) | $85.89 M(+2.2%) |
| Sept 2018 | - | $84.08 M(-4.5%) |
| June 2018 | - | $88.04 M(-3.9%) |
| Mar 2018 | - | $91.65 M(+222.1%) |
| Dec 2017 | $28.45 M(-20.0%) | $28.45 M(-15.7%) |
| Sept 2017 | - | $33.77 M(+0.4%) |
| June 2017 | - | $33.65 M(-3.0%) |
| Mar 2017 | - | $34.68 M(-2.5%) |
| Dec 2016 | $35.57 M(-16.2%) | $35.57 M(-2.0%) |
| Sept 2016 | - | $36.28 M(-3.0%) |
| June 2016 | - | $37.42 M(-5.7%) |
| Mar 2016 | - | $39.69 M(-6.5%) |
| Dec 2015 | $42.45 M(+5.0%) | $42.45 M(+8.1%) |
| Sept 2015 | - | $39.27 M(-10.3%) |
| June 2015 | - | $43.76 M(+0.3%) |
| Mar 2015 | - | $43.62 M(+7.8%) |
| Dec 2014 | $40.45 M(-1.3%) | $40.45 M(+2.8%) |
| Sept 2014 | - | $39.35 M(-0.3%) |
| June 2014 | - | $39.48 M(+1.0%) |
| Mar 2014 | - | $39.11 M(-4.6%) |
| Dec 2013 | $40.98 M(+40.0%) | $40.98 M(+1.2%) |
| Sept 2013 | - | $40.50 M(-0.4%) |
| June 2013 | - | $40.67 M(+31.0%) |
| Mar 2013 | - | $31.05 M(+6.1%) |
| Dec 2012 | $29.27 M | $29.27 M(-3.1%) |
| Sept 2012 | - | $30.22 M(-4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $31.52 M(-5.6%) |
| Mar 2012 | - | $33.40 M(+7.3%) |
| Dec 2011 | $31.14 M(-9.9%) | $31.14 M(+0.5%) |
| Sept 2011 | - | $30.99 M(-3.8%) |
| June 2011 | - | $32.20 M(-3.5%) |
| Mar 2011 | - | $33.38 M(-3.4%) |
| Dec 2010 | $34.55 M(+8.1%) | $34.55 M(+8.3%) |
| Sept 2010 | - | $31.91 M(+16.4%) |
| June 2010 | - | $27.42 M(-8.8%) |
| Mar 2010 | - | $30.07 M(-6.0%) |
| Dec 2009 | $31.97 M(+119.7%) | $31.97 M(-7.6%) |
| Sept 2009 | - | $34.60 M(+173.7%) |
| June 2009 | - | $12.64 M(-4.4%) |
| Mar 2009 | - | $13.22 M(-9.1%) |
| Dec 2008 | $14.55 M(-41.1%) | $14.55 M(+0.5%) |
| Sept 2008 | - | $14.49 M(-18.9%) |
| June 2008 | - | $17.86 M(-0.4%) |
| Mar 2008 | - | $17.94 M(-27.4%) |
| Dec 2007 | $24.72 M(+15.8%) | $24.72 M(+17.7%) |
| Sept 2007 | - | $21.00 M(+18.9%) |
| June 2007 | - | $17.66 M(-4.4%) |
| Mar 2007 | - | $18.47 M(-13.5%) |
| Dec 2006 | $21.34 M(-8.1%) | $21.34 M(+17.5%) |
| Sept 2006 | - | $18.16 M(-12.4%) |
| June 2006 | - | $20.73 M(-6.4%) |
| Mar 2006 | - | $22.14 M(-4.6%) |
| Dec 2005 | $23.22 M(-34.6%) | $23.22 M(-28.0%) |
| Sept 2005 | - | $32.24 M(-3.0%) |
| June 2005 | - | $33.24 M(+3.8%) |
| Mar 2005 | - | $32.04 M(-9.8%) |
| Dec 2004 | $35.52 M(+20.2%) | $35.52 M(+7.1%) |
| Sept 2004 | - | $33.16 M(-1.4%) |
| June 2004 | - | $33.64 M(-7.3%) |
| Mar 2004 | - | $36.30 M(+22.8%) |
| Dec 2003 | $29.55 M(+53.9%) | $29.55 M(+15.4%) |
| Sept 2003 | - | $25.60 M(+2.6%) |
| June 2003 | - | $24.96 M(-5.9%) |
| Mar 2003 | - | $26.54 M(+38.2%) |
| Dec 2002 | $19.20 M(+23.5%) | $19.20 M(+50.7%) |
| Sept 2002 | - | $12.74 M(+5.7%) |
| June 2002 | - | $12.06 M(-20.3%) |
| Mar 2002 | - | $15.12 M(-2.8%) |
| Dec 2001 | $15.55 M(+140.2%) | $15.55 M(+98.7%) |
| Sept 2001 | - | $7.83 M(-4.8%) |
| June 2001 | - | $8.22 M(+74.8%) |
| Mar 2001 | - | $4.70 M(-27.4%) |
| Dec 2000 | $6.47 M(-48.7%) | $6.47 M |
| Dec 1999 | $12.63 M(+93.0%) | - |
| Dec 1998 | $6.54 M | - |
FAQ
- What is Harvard Bioscience annual total liabilities?
- What is the all time high annual total liabilities for Harvard Bioscience?
- What is Harvard Bioscience quarterly total liabilities?
- What is the all time high quarterly total liabilities for Harvard Bioscience?
- What is Harvard Bioscience quarterly total liabilities year-on-year change?
What is Harvard Bioscience annual total liabilities?
The current annual total liabilities of HBIO is $64.29 M
What is the all time high annual total liabilities for Harvard Bioscience?
Harvard Bioscience all-time high annual total liabilities is $85.89 M
What is Harvard Bioscience quarterly total liabilities?
The current quarterly total liabilities of HBIO is $65.92 M
What is the all time high quarterly total liabilities for Harvard Bioscience?
Harvard Bioscience all-time high quarterly total liabilities is $91.65 M
What is Harvard Bioscience quarterly total liabilities year-on-year change?
Over the past year, HBIO quarterly total liabilities has changed by +$1.63 M (+2.53%)